Nurimanov Chingiz, Mammadinova Iroda, Menlibayeva Karashash, Kaliyev Assylbek, Makhambetov Yerbol, Akshulakov Serik
Vascular and Functional Neurosurgery Department, National Centre for Neurosurgery, Astana, Kazakhstan.
Hospital Management Department, National Centre for Neurosurgery, Astana, Kazakhstan.
Front Surg. 2024 May 22;11:1378717. doi: 10.3389/fsurg.2024.1378717. eCollection 2024.
Microvascular decompression (MVD) remains the primary surgical treatment for trigeminal neuralgia due to its positive postoperative results. This study aims to evaluate the outcomes of patients with primary trigeminal neuralgia who underwent MVD. Additionally, the paper offers a detailed explanation of the surgical methodology of MVD employed at the neurosurgical hospital in Kazakhstan.
The study involved 165 medical records of patients with trigeminal neuralgia who underwent MVD between 2018 and 2020. Out of these 165 patients, 90 (54.55%) were included in the final analysis and were further evaluated using the Barrow Neurological Institute pain intensity score. Various variables were analyzed, including age, sex, affected side, dermatomes, offending vessel, and surgical intervention type. Moreover, the surgical technique employed at the hospital was described.
The average follow-up period after the MVD procedure was 32.78 ± 9.91 months. The results indicated that out of the 90 patients, 80 (88.89%) achieved a good outcome as evidenced by BNI scores I and II. It was observed that patients with affected maxillary dermatomas and those with affected ophthalmic + maxillary dermatomas were more likely to experience fair + poor postsurgery BNI scores. On the other hand, patients with neurovascular conflicts involving the maxillary + mandibular dermatomas demonstrated good BNI scores ( = 0.01).
The outcomes of MVD in patients with primary trigeminal neuralgia showed good BNI scores within this study population. The outcome depended on the affected dermatome of the trigeminal nerve with the vessel. Additionally, patient positioning, intraoperative management including small skin incisions, minimal craniotomy, and precise closure of the dura, as well as intraoperative neurolysis, may contribute to achieving good clinical and satisfactory post-surgery aesthetic outcomes.
微血管减压术(MVD)因其良好的术后效果,仍然是三叉神经痛的主要外科治疗方法。本研究旨在评估接受MVD治疗的原发性三叉神经痛患者的治疗效果。此外,本文还详细介绍了哈萨克斯坦神经外科医院采用的MVD手术方法。
本研究纳入了2018年至2020年间接受MVD治疗的165例三叉神经痛患者的病历。在这165例患者中,90例(54.55%)纳入最终分析,并使用巴罗神经学研究所疼痛强度评分进行进一步评估。分析了各种变量,包括年龄、性别、患侧、皮节、责任血管和手术干预类型。此外,还描述了该医院采用的手术技术。
MVD手术后的平均随访期为32.78±9.91个月。结果表明,在90例患者中,80例(88.89%)取得了良好的效果,巴罗神经学研究所疼痛强度评分为I级和II级。观察到上颌皮节受累的患者以及眼支+上颌皮节受累的患者术后巴罗神经学研究所疼痛强度评分更有可能为中等+差。另一方面,涉及上颌+下颌皮节的神经血管冲突患者的巴罗神经学研究所疼痛强度评分良好(P = 0.01)。
在本研究人群中,原发性三叉神经痛患者接受MVD治疗的效果显示出良好的巴罗神经学研究所疼痛强度评分。治疗效果取决于三叉神经与血管受累的皮节。此外,患者体位、术中管理(包括小皮肤切口、最小开颅手术和硬脑膜的精确缝合)以及术中神经松解术,可能有助于实现良好的临床效果和令人满意的术后美学效果。